Atlas Trials

Transplant Patients With EBV Viremia at High Risk for Developing a Recurrent EBV Lymphoma

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Transplant Patients With EBV Viremia at High Risk for Developing a Recurrent EBV Lymphoma

RecordFirmDate
Therapeutic Effects of Epstein-Barr Virus Immune T-Lymphocytes Derived From a Normal HLA-Compatible Or Partially-Matched Third-Party Donor in the Treatment of EBV Lymphoproliferative Disorders and EBV-Associated Malignancies (NCT01498484)Atara Biotherapeutics2011-12-01

Track Transplant Patients With EBV Viremia at High Risk for Developing a Recurrent EBV Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.